Iovance Biotherapeutics Inc. – Underwriting Agreements Watch

from 8-K 40 pages Iovance Biotherapeutics, Inc., a Delaware Corporation (The “Company”), Proposes, Subject to the Terms and Conditions Stated Herein, to Issue and Sell From Time to Time Through Jefferies LLC, as Sales Agent and/or Principal (The “Agent”), Shares of the Company’s Common Stock, Par Value $0.000041666 Per Share (The “Common Shares”) on the Terms Set Forth in This Amended and Restated Agreement (This “Agreement”). Whereas, the Agent and the Company Are Parties to That Certain Open Market Sale Agreementsm Dated as of June 16, 2023 (The “Original Agreement”); and Whereas, the Agent and the Company Desire to Amend and Restate the Original Agreement on the Terms and Conditions Set Forth Herein. Now, Therefore, in Consideration of the Mutual Promises Herein Contained, the Agent and the Company Agree as Follows: Section 1. Definitions (A) Certain Definitions. for Purposes of This Agreement, Capitalized Terms Used Herein and Not Otherwise Defined Shall Have the Following Respective Meanings

from 8-K 54 pages 23,014,000 Shares Iovance Biotherapeutics, Inc. Underwriting Agreement

from 8-K 45 pages 20,000,000 Shares Iovance Biotherapeutics, Inc. Underwriting Agreement

from 8-K 39 pages Open Market Sale Agreementsm

from 8-K 39 pages Open Market Sale Agreementsm

from 8-K 37 pages Iovance Biotherapeutics, Inc., a Delaware Corporation (The “Company”), Proposes, Subject to the Terms and Conditions Stated Herein, to Issue and Sell From Time to Time Through Jefferies LLC, as Sales Agent and/or Principal (The “Agent”), Shares of the Company’s Common Stock, Par Value $0.000041666 Per Share (The “Common Shares”), Having an Aggregate Offering Price of Up to $350,000,000 on the Terms Set Forth in This Agreement (This “Agreement”). Section 1. Definitions (A) Certain Definitions. for Purposes of This Agreement, Capitalized Terms Used Herein and Not Otherwise Defined Shall Have the Following Respective Meanings

from 8-K 52 pages 16,935,484 Shares Iovance Biotherapeutics, Inc. Underwriting Agreement

from 8-K 39 pages 22,000,000 Shares Iovance Biotherapeutics, Inc. Underwriting Agreement

from 8-K 36 pages 13,043,479 Shares Iovance Biotherapeutics, Inc. Underwriting Agreement

from 8-K 38 pages 7,692,308 Shares Iovance Biotherapeutics, Inc. Underwriting Agreement

from 8-K 46 pages 4,750,000 Shares Lion Biotechnologies, Inc. Underwriting Agreement

from 8-K 38 pages 8,000,000 Shares Lion Biotechnologies, Inc. Underwriting Agreement

from 8-K 37 pages 5,217,392 Shares Lion Biotechnologies, Inc. Underwriting Agreement

from SC 13G 1 page Joint Filing Agreement

from SC 13D/A 4 pages Advisory Agreement